Licensing is the area of expertise that is based on establishing contacts and getting commitments from clients to use our registration dossiers for submission at Health Authorities after we have done the development and research to create the dossier, in return for a licensing fee.

Our preferred business model is licensing linked to supply though we are open to discuss other business models if this creates a win-win situation for both companies.

We try to adjust our pricing strategy in function of market conditions in each of the clients’ territory of interest.

Based on the constant development of new molecules we team-up with strategic partners who add our developments to their portfolio thus creating synergy.

Marketing Authorizations

Neogen and our partners have large and extensive Marketing Authorizations in several EU/Non EU countries.

What we can offer

Being a client of Neogen means for you that we prepare and deliver Dossiers (E-CTD ready format) for you to get approvals from the Authorities.

Our main activity is the development, licensing, and supply of generic products.

For all enquiries regarding new business, please send an e-mail to licensing@neogen.be

We offer a significant Product Portfolio

Meet Our Licensing Team

Bruno Febra

Head of Commercial and Business Development Generics EU/ROW

Esther Kranenburg

Head of Licensing

Responsible for licensing in Australia, New Zealand, United Kingdom, Ireland, Benelux, Germany, Switzerland, Austria and RSA

Jolanta Liszewska

Senior Business Development & Licensing Manager

Responsible for licensing in China, Poland, Baltics, Czech Republic, Slovakia, Hungary, Bulgaria, Serbia, Bosnia and Herzegovina.

Daniel Santos

Senior Business Development & Licensing Manager

Responsible for licensing in Portugal, Spain, Italy, MENA, Latam

Comments are closed.